World's 1st trial of drug developed from iPS cells to begin

Junya Toguchida, professor at Kyoto University, speaks at a press conference in Kyoto on Aug. 1, 2017, announcing that his team will begin the world's first clinical trial of a drug developed from induced pluripotent stem cells to treat fibrodysplasia ossificans progressiva, a rare bone disease. (Kyodo) ==Kyodo